36
https://pubmed.ncbi.nlm.nih.gov/38115365
Polycystic ovary syndrome (PCOS) pathogenesis is significantly influenced by gut microbiota dysbiosis, implicating specific bacterial strains and their metabolic byproducts as potential therapeutic targets, according to this review.